Member Info for CHELSEA7

Buys 14k

Sells 92k

Me thinks in view of the two new appointments, Scancell know something we dont know. No surprises in there at all.

The RNS is what it is, not dressed up, they never are.

7/7.5

23k sold at 7p!!!

Would you believe we are top of share chat, and been it 4/5 days in the last week. Very few posts as well, the exodus is startling.

As for an interim report,well it is what it is, and IMHO no surprises there.

Like London buses, the first of a few RNSs

Ruck, they have discussed SCIB1, and SCIB2 newsflow and action comes via CRUK. MOD1 vaccine being maufactured, working on MOD2. Hmmm, your post Ruck is not your finest

Yep, Polypeptide too. Hence on these 3 items alone there are some one off payments.

Sorry 400k a month

Terms we undisclosed, but yes a possibility. Considering both items monthly expeniture should be running about 400k a week maybe, £5m a year.

Where do you get £8m from Ruck?

Terms we undisclosed, but yes a possibility. Considering both items monthly expeniture should be running about 400k a week maybe, £5m a year.

Where do you get £8m from Ruck?

Looking for any possibility of one off payments and it seems payment for the SCIB1 vaccine could well be included. That would of cost up to £1m I seem to remember.

Doesn"t really tell us too much. Example, is the payment for SCIB 1 vaccine included in that?

https://www.investegate.co.uk/scancell-hlds--sclp-/rns/interim-results/201901310700086058O/

Didn"t notice it had 729 views, that helps show the interest in us. I understand how many of us feel,however, surprised to see a lack of buying at 7.50. We reached a high last year of 19.25, we certainly have more upside than down based on that, lol!!

Time for tea, R. N..S!!!

So glad you post Crumbs, you always put it more succinctly than me, agreed, i laugh how often our posts cross and hanoi hope that helps answer your thoughts.

It just amazes me how much we are not party too, have to make decisions on, and it comes down to the balance of probability. I found those two new appointments very positive signs, and whilst we get accused of talking "rhubarb" to one another, i.e. not afraid to have an opinion based on something, still those who look at this negatively, are quick to point fingers without reason, and lambast the B,O,D for not doing what we don"t exactly know what or why.

The share rose 14% on that announcement , Monday a week ago, and more the following day with GC in mind, Fierce Biotech spoke highly of the two appointments, and how good to see them picking up on us, a lot to do with the company we are keeping IMHO.

Morning hanoi, yeah shocking wasn"t it. Who will be our next manager, lol?

Well Moditope Patent News and the SCIB1 IND for starters, possible SCIB2 trial news, then we have the Moditope/TCR platforms which could come at any time. TBH I was just happy to get sub 8p,IMO the upside far outweighs the downside.

Hospital, hmmm, definately cannot have Radiotherapy, Surgery or Radiation, still in talks, most of last week, but my other conditions have worsened, so any possible alternatives well they all have side effects, so still in talks but looking like i won"t opt for anything. Hard to explain the other conditions and just how much they affect me, but i know my body won"t take much more and so far all the oncologists agree. A really hard one, but a damn good reason why i hope for news soon!!!!

Hope you are good hanoi, thanks for asking, really not comfortable discussing it, feels very surreal, and not something i can discuss with friends really, only i can decide, and that is very hard.

So yes doubled my holding, I jest not when i say my interest here keeps me punching. ATVB

Take Care

Hi Gilders, it really can be mate. I guess for me it keeps me going, and yes now no longer in business offers an opportunity every day to feel emotionally and financially involved.

Didn"t know you were in here, welcome to the BB buddy.

This is the interview between Proactive Investors--Andrew Scott and Cliff Holloway after the GC results.

I hadn"t seen it before, so a repost for others who missed it too. Down 25%......really!!!

https://www.youtube.com/watch?v=gBTaKD518yY

Really weird, from sleeping for two days at a time, can hardly sleep all week. I think it is largely due to increasing my holding to 213k, looking forward to some positive news, and arguably even though i have no real desire to fill my time trading other shares, it is the anticipation every day of good news that keeps me on my toes.

A few have asked about inflection points recently, and apart from a very good commercial deal i actually feel we need a combination of good news to light the sparkle again. The Moditope Patent we expect now, Thursday RNSs are not uncommon, but just watching level 2 this week, I get the feeling our big seller has gone lower enough for now. I think the item of news which is seeing us slowly fall now is the IND and the possibility of further delays to Trial.

Whatever it is that has brought or M/Cap below £30m, i really had a feeling we wouldn"t go under it, certainly not on the news we are privy too, and considering 10p was paid 6 times last week, someone brought at 7.48 late yesterday So reallyy hoping these two items of news are RNSed ASAP.. Mentioned before i have seen two e-mails, one from CH the other from RG, and whilst i have never seen any price sensitive news sent from Scancell, both seemed confidant the IND news will be ours soon and both cited the FDA as a cause of delay now the forms have been re sumitted.

Things change very quickly don"t they, just look at Chelsea last night, lol. I think we could sell 70k at 7.22 last night, considering what could be coming the sells at 7.20 surprise me, but the buys are outweighing the sells for now. A blue day please, and an RNS would be even better.

Hi yer Jeremy, hope your good buddy.

Heard about this a few times today, this comes from the link you provided, which kinda mirrored my thoughts too..........

This is a news report based on limited information provided by researchers and a company working on this technology. It apparently has not been published in the scientific literature where it would be subject to review, support and/or criticism from knowledgeable peers.
My colleagues here at American Cancer Society tell me phage or peptide display techniques, while very powerful research tools for selecting high affinity binders, have had a difficult road as potential drugs. If this group is just beginning clinical trials, they may well have some difficult experiments ahead.
This is based on a mouse experiment which is described as “exploratory.” It appears at this point there is not a well-established program of experiments which could better define how this works—and may not work—as it moves from the laboratory bench to the clinic.

Take care Jeremy